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Errata and Corrigenda 
The publishers and the authors would like to make the following corrections: 
Young, A.A., Cracker, L.B.,Wolfe-Lopez, D. and Cooper, G.J.S., Daily amylin replacement reverses hepatic glyco- 
gen depletion in insulin-treated streptozotocin diabetic rats (1991) FEBS Letters 287, 203-205 
Due to a numerical error in the derivation of hepatic glycogen contents, published values should be multiplied by 
a factor of 6.19. The conclusions of the paper are not altered; the P value at an amylin dose of 30 ,uglday changes 
from < 0.02 to < 0.03. 
Arcone, R., Fontaine, V., Coto, I., Content, J., Brakenhoff, J.P.J. and Ciliberto, G., Internal deletions of amino acids 
29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding (1991) FEBS Letters 288, 197-200 
The name and address of Author Brakenhoff was omitted. The correct list of authors and their affiliations should 
have been as follows: 
Rosaria Arcone’, Veronique Fontaine 2, Iolanda Coto’, Just P.J. Brakenhoff3, Jean Content2 and 
Gennaro Ciliberto4 
‘CEINGE, Centro di Ingegneria Geneticu, Via S. Pansini 5, 80131, Nupoli, Italy, ‘Institut Pasteur du Brabant, Department of 
Virology, 1180 Bruxelles, Belgium, 3C:entral Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, 
The Nether1and.r and 41. R.B.M., Via Pontina km 30,600, 00040 Pomezia, Rome, Italy 
The list of points made in section 3, Results and Discussion, p. 199, should have been as follows: 
- Wild-type IL-6 is recognized at high efficiency by mAb 8 but not by mAb 7. 
- The active mutant 439-42 behaves similarly, but here there is a moderate reaction with mAb 7, probably a sign 
of partial denaturdtion of the protein. This result is in line with the slight decrease of activity that this mutant protein 
shows. 
- Mutants 431-34 and A35~-38 behave inversely: their recognition by mAb 8 is considerably decreased and at the 
same time the mutant proteins are precipitated efficiently by mAb 7 (ratio mAb 7/mAb 8=0.8). This is clear evidence 
that these proteins are denaturated, and explains lack of activity. 
_ The most interesting mutant is 429-30. Its immunoreactivity is intermediate between that of mutant 439-42 and 
that ofmutants 431-34 and 435-38 (ratio mAb 7/mAb 8x0.56). This leads to the conclusion that the deletion of amino 
acids 29-30 is accompanied by a minor degree of structural alteration but its bioactivity is lo- to 20-fold lower than 
that of 435-38. 
Table II, p, 200 was also incorrect and should have been as follows: 
Table 11 
Conformational analysis of the deletion mutants 
Proteins Immunoprecipitation with or without 
polyclonal Ab mAb 7 mAb 8 mAb 7lmAb 8 anti IL-6 Ab 
wt IL-6 + ++ 0.08 _ 
429-30 + + ++ 0.56 
431-34 + ++ ++ 0.77 
A35 m~38 + + + 0.81 _ 
439-42 + ii- ++ 0.26 _ 
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